Zobrazeno 1 - 10 of 5 087 pro vyhledávání: '"Moisan, J"'
1
Report
Experimental study of the $^{40,48}$Ca+ $^{40,48}$Ca reactions at 35 MeV/nucleon
Autor: Fable, Q., Chbihi, A., Boisjoli, M., Frankland, J. D., Fèvre, A. Le, Neindre, N. Le, Marini, P., Verde, G., Ademard, G., Bardelli, L., Bhattacharya, C., Bhattacharya, S., Bonnet, E., Borderie, B., Bougault, R., Casini, G., Commara, M., Dayras, R., Ducret, J. E., Farget, F., Galichet, E., Génard, T., Gramegna, F., Gruyer, D., Henri, M., Kundu, S., Lemarié, J., Lopez, Olivier, Łukasik, J., Manduci, L., Moisan, J., Mukherjee, G., Napolitani, P., Olmi, A., Pârlog, M., Piantelli, S., Poggi, G., Rebillard-Soulié, A., Roy, R., Sorgunlu, B., Velardita, S., Vient, E., Vigilante, M., Wieleczko, J. P.
Publikováno v: Physical Review C, American Physical Society, 2022, 106 (2), pp.024605
In this article we investigate $^{40,48}$Ca+$^{40,48}$Ca peripheral and semi-peripheral reactions at 35 MeV/nucleon. Data were obtained using the unique coupling of the VAMOS high acceptance spectrometer and the INDRA charged particle multidetector.T
Externí odkaz: http://arxiv.org/abs/2202.13850
Zobrazit plný text záznamu
3
Akademický článek
Corrigendum for Guenette L, Breton MC, Guillaumie L, Lauzier S, Gregoire JP, Moisan J. Psychosocial factors associated with adherence to non-insulin antidiabetes treatments. J Diabetes Complications 2016; 30:335-42.
Publikováno v: Journal of diabetes and its complications [J Diabetes Complications] 2017 Sep; Vol. 31 (9), pp. 1475.
Zobrazit plný text záznamu
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Symptomatology and Management of Adult Anaphylaxis according to Trigger: A Cross-Sectional Study.
Autor: Khalaf R; Faculty of Medicine, McGill University, Montreal, Québec, Canada., Prosty C; Faculty of Medicine, McGill University, Montreal, Québec, Canada., McCusker C; Department of Pediatrics, Division of Allergy Immunology and Dermatology, McGill University Health Centre, Montreal, Québec, Canada., Bretholz A; Department of Pediatrics- McGill University Health Centre, Montreal, Québec, Canada., Kaouache M; Department of Pediatrics, Division of Allergy Immunology and Dermatology, McGill University Health Centre, Montreal, Québec, Canada., Clarke AE; Department of Medicine, Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Morris J; Department of Emergency Medicine, Sacré-Coeur Hôpital, Montreal, Québec, Canada., Lim R; Division of Pediatric Emergency Medicine, Department of Pediatrics, Children's Hospital at London Health Science Centre, London, Ontario, Canada., Chan ES; Division of Allergy and Immunology, Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Goldman RD; Division of Clinical Pharmacology and Emergency Medicine, Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., O'Keefe A; Department of Pediatrics, Faculty of Medicine, Memorial University, St John's, Newfoundland, Canada., Gerdts J; Executive Director, Food Allergy Canada, Toronto, Ontario, Canada., Chu DK; Division of Clinical Immunology and Allergy, Department of Medicine, and Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada., Upton J; Division of Immunology and Allergy, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Hochstadter E; Department of Pediatric Emergency Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Moisan J; Regional Medical Director of Emergency Medical Services of Outaouais, Outaouais, Québec, Canada., Zhang X; Centre for Outcomes Research and Evaluation, Research Institute of McGill University Health Centre, Montreal, Québec, Canada., Protudier JLP; Department of Pediatrics and Child Health, Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada., Abrams E; Department of Pediatrics and Child Health, Section of Allergy and Clinical Immunology, Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada., Simons E; Department of Pediatrics and Child Health, Section of Allergy and Clinical Immunology, Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada., Ruiz J; Faculty of Allergy and Immunology, Vancouver General Hospital, Vancouver, British Columbia, Canada., Ben-Shoshan M; Faculty of Medicine, McGill University, Montreal, Québec, Canada.; Department of Pediatrics, Division of Allergy Immunology and Dermatology, McGill University Health Centre, Montreal, Québec, Canada.
Publikováno v: International archives of allergy and immunology [Int Arch Allergy Immunol] 2024 Nov 15, pp. 1-11. Date of Electronic Publication: 2024 Nov 15.
Zobrazit plný text záznamu
7
Akademický článek
Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In Vivo.
Autor: Schiemann K; The Healthcare Business of Merck KGaA, Darmstadt, Germany., Belousova N; EMD Serono, Billerica, Massachusetts., Matevossian A; EMD Serono, Billerica, Massachusetts., Nallaparaju KC; EMD Serono, Billerica, Massachusetts., Kradjian G; EMD Serono, Billerica, Massachusetts., Pandya M; EMD Serono, Billerica, Massachusetts., Chen Z; EMD Serono, Billerica, Massachusetts., Aral E; EMD Serono, Billerica, Massachusetts., Krauel EM; EMD Serono, Billerica, Massachusetts., Petrova E; The Healthcare Business of Merck KGaA, Darmstadt, Germany., Boesler C; The Healthcare Business of Merck KGaA, Darmstadt, Germany., Kitzing T; The Healthcare Business of Merck KGaA, Darmstadt, Germany., Lecomte M; The Healthcare Business of Merck KGaA, Darmstadt, Germany., Wagner C; The Healthcare Business of Merck KGaA, Darmstadt, Germany., Blayo AL; Domain Therapeutics SA, Strasbourg, France., Schann S; Domain Therapeutics SA, Strasbourg, France., Huck B; EMD Serono, Billerica, Massachusetts., Moisan J; EMD Serono, Billerica, Massachusetts., Zaynagetdinov R; EMD Serono, Billerica, Massachusetts.
Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2024 Nov 04; Vol. 23 (11), pp. 1517-1529.
Zobrazit plný text záznamu
8
Report
Evolution of the decay mechanisms in central collisions of $Xe$ + $Sn$ from $E/A$ = 8 to 29 $MeV$
Autor: Chbihi, A., Manduci, L., Moisan, J., Bonnet, E., Frankland, J. D., Roy, R., Verde, G.
Collisions of Xe+Sn at beam energies of $E/A$ = 8 to 29 $MeV$ and leading to fusion-like heavy residues are studied using the $4\pi$ INDRA multidetector. The fusion cross section was measured and shows a maximum at $E/A$ = 18-20 $MeV$. A decompositio
Externí odkaz: http://arxiv.org/abs/1209.6164
Zobrazit plný text záznamu
9
Report
Decay of excited nuclei produced in $^{78,82}$Kr + $^{40}$Ca reactions at 5.5 MeV/nucleon
Autor: Ademard, G., Wieleczko, J. P., Del Campo, J. Gomez, La Commara, M., Bonnet, E., Vigilante, M., Chbihi, A., Frankland, J. D., Rosato, E., Spadaccini, G., Kalandarov, Sh. A., Beck, C., Barlini, S., Borderie, B., Bougault, R., Dayras, R., De Angelis, G., De Sanctis, J., Kravchuk, V. L., Lautesse, P., Neindre, N. Le, Moisan, J., D'onofrio, A., Parlog, M., Pierroutsakou, D., Rivet, M. F., Romoli, M., Roy, R., Adamian, G. G., Antonenko, N. V.
Publikováno v: Phys.Rev.C83:054619,2011
Decay modes of excited nuclei are investigated in $^{78,82}$Kr + $^{40}$Ca reactions at 5.5 MeV/nucleon. Charged products were measured by means of the $4\pi$ INDRA array. Kinetic-energy spectra and angular distributions of fragments with atomic numb
Externí odkaz: http://arxiv.org/abs/1104.4020
Zobrazit plný text záznamu
10
Akademický článek
Symptomatology and management of peanut anaphylaxis: A cross-sectional study.
Autor: Khalaf R; Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada. Electronic address: roy.khalaf@mail.mcgill.ca., Prosty C; Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada., McCusker C; Division of Allergy Immunology and Dermatology, Department of Pediatrics, McGill University Health Centre, Montreal, Quebec, Canada., Bretholz A; Department of Pediatrics, McGill University Health Centre, Montreal, Quebec, Canada., Kaouache M; Division of Allergy Immunology and Dermatology, Department of Pediatrics, McGill University Health Centre, Montreal, Quebec, Canada., Clarke AE; Division of Rheumatology, Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Morris J; Department of Emergency Medicine, Sacré-Coeur Hôpital, Montreal, Quebec, Canada., Gravel J; Department of Pediatric Emergency Medicine, Centre Hospitalier Universitaire Sainte-Justine Université de Montréal, Montreal, Quebec, Canada., Lim R; Division of Pediatric Emergency Medicine, Department of Pediatrics, Children's Hospital at London Health Science Centre, London, Ontario, Canada., Chan ES; Division of Allergy and Immunology, Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Goldman RD; Division of Clinical Pharmacology and Emergency Medicine, Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., O' Keefe A; Department of Pediatrics, Faculty of Medicine, Memorial University, St John's, Newfoundland & Labrador, Canada., Gerdts J; Food Allergy Canada, Toronto, Ontario, Canada., Chu DK; Division of Clinical Immunology and Allergy, Department of Medicine, and Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada., Upton J; Division of Immunology and Allergy, Department of Pediatrics, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada., Hochstadter E; Department of Pediatric Emergency Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Moisan J; Emergency Medical Services of Outaouais, Outaouais, Quebec, Canada., Zhang X; Centre for Outcomes Research and Evaluation, Research Institute of McGill University Health Centre, Montreal, Quebec, Canada., Protudjer JLP; Department of Pediatrics and Child Health, Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada., Abrams EM; Section of Allergy and Clinical Immunology, Department of Pediatrics and Child Health, Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada., Simons E; Section of Allergy and Clinical Immunology, Department of Pediatrics and Child Health, Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada., Ruiz J; Division of Allergy and Immunology, Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Ben-Shoshan M; Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada; Division of Allergy Immunology and Dermatology, Department of Pediatrics, McGill University Health Centre, Montreal, Quebec, Canada.
Publikováno v: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2024 Sep 27. Date of Electronic Publication: 2024 Sep 27.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje